The New York Times published a misleading profile of Medvi, portraying it as an AI-powered telehealth startup valued at $1.8 billion despite lacking credible valuation metrics and facing significant legal issues. This misrepresentation highlights the risks of uncritical reporting on emerging tech trends, potentially misleading developers and consumers about ethical business practices in AI.
Read the full article at TechDirt
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.



